Molecular cloning of the canine nicotinic acetylcholine receptor α-subunit gene and development of the ELISA method to diagnose myasthenia gravis

Veterinary Immunology and Immunopathology

Volumn 72, Issue 3-4, 1999, Pages 315-324

  Yoshioka, T ^a   Uzuka, Y ^a   Tanabe, S ^a   Sarashina, T ^a   Ishiguro, N ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

AChR; DNA; Dog; ELISA; MG

Indexed keywords

COMPLEMENTARY DNA; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; MOLECULAR CLONING; MYASTHENIA GRAVIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SKELETAL MUSCLE; TECHNIQUE;

ACETYLCHOLINE; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; BASE SEQUENCE; BINDING SITES; CLONING, MOLECULAR; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; POLYMERASE CHAIN REACTION; RABBITS; RECEPTORS, NICOTINIC; SEQUENCE ANALYSIS, DNA;

EID: 0032795068     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(99)00140-3     Document Type: Article

References (16)

1. Barchan D., Ovadia M., Kochva E., Fuchs S. The binding site of the nicotinic acetylcholine receptor in animal species resistant to α-bungarotoxin. Biochemistry. 34:1995;9172-9176.
2. Cockcroft V.B., Lunt G.G., Osguthorpe D.J. Modelling of binding sites of the nicotinic acetylcholine receptor and their relation to models of the whole receptor. Biochem. Soc. Symp. 57:1990;65-79.
3. Drachman D.B. Biology of myasthenia gravis. Annu. Rev. Neurosci. 4:1981;195-225.
4. Garlepp A., Farrow B., Kay P., Dawkins L. Antibodies to the acetylcholine receptor in myasthenic dogs. Immunology. 37:1979;807-810.
5. Lennon V.A., Griesmann G.E. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis. Neurology. 39:1989;1069-1076.
6. Lindstrom J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin. Immunol. Immunopathol. 7:1977;36-43.
7. Lindstrom J., Shelton G.D., Fujii Y. Myasthenia gravis. Adv. Immunol. 42:1988;233-284.
8. Martino G., Twaddle G., Brambilla E., Grimaldi L.M.E. Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line. Acta Neurol. Scand. 89:1994;18-22.
9. Onodera H., Ishiguro N., Horiuchi M., Shinagawa M. Characterization of differentially expressed genes in the bovine T lymphoma cell line. Vet. Immunol. Immunopathol. 62:1998;209-219.
10. Shelton G.D., Cardinet III G.H., Lindstrom J.M. Canine and human myasthenia gravis autoantibodies recognize similar regions on the acetylcholine receptor. Neurology. 38:1988;1417-1423.
11. Shelton G.D., Schule A., Kass P.H. Risk factors for acquired myasthenia gravis in dogs: 1154 cases (1991-1995). J. Am. Vet. Med. Associ. 211:1997;1428-1431.
12. Shelton G.D., Willard M.D., Cardinet III G.H., Lindstrom J. Acquired myasthenia gravis. J. Vet. Inter. Med. 4:1990;281-284.
13. Takamori M., Okumura S., Ide Y. A synthetic peptide, Torpedo california α183-200, of the acetylcholine receptor as a tool for immunoadsorption via plasma perfusion in myasthenia gravis. Artif. Organs. Today. 1:1991;53-57.
14. Takamori M., Okumura S., Nagata M., Yoshikawa H. Myasthenogenic significance of aynthetic α-subunit peptide 183-200 of Torpedo california and human acetylcholine receptor. J. Neurol. Sci. 85:1988;121-129.
15. Tzartos S.J., Cung M.T., Demange P., Loutrari H., Mamalaki A., Marraud M., Papadouli I., Sakarellos C., Tsikanis V. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies. Mol. Neurobiol. 5:1992;1-29.
16. Wu J.T., Miya T.G., Knight J.A., Bringhurst C. Acetylcholine receptors from normal human muscle: concentration, purification, and use in radioreceptor assays for autoantibodies. J. Clin. Lab. Anal. 5:1991;79-85.